|
Bendamustine |
25mg/1ml, 100mg/4ml, 200mg/8ml |
|
|
Bortezomib |
IP 2mg/vial, 3.5 mg/vial |
|
|
Carboplatin |
IP/BP 150mg/15 ml, 450mg/45ml |
|
|
Cytarabine |
BP 100 mg/ml, 500 mg/5 ml |
|
|
Dacarbazine |
USP 200mg/vial, 500mg/vial |
|
|
Docetaxel |
IP/USP 20mg/0.5ml, 80mg/2ml |
Under Development |
|
Doxorubicin Hydrochloride |
10mg/5ml, 50mg/25ml |
Under Development |
|
Epirubicin |
10mg/vial, 50mg/vial, 100mg/vial |
|
|
Eribulin Mesylate |
0.5mg, 0.88mg/2ml |
Under Development |
|
Fluorouracil |
1000mg/20ml, 5000mg/100ml, 500mg/10ml, 250mg/5ml |
|
|
Gemcitabine |
IP/USP 200mg/vial, lgm/vial, 1.4gm/vial |
|
|
Irinotecan Hydrochloride |
IP/USP 40mg/2ml, 100mg/5ml, 300mg/5ml |
Under Development |
|
Methotrexate |
IP/USP 500mg/20ml, 50mg/2ml |
|
|
Oxaliplatin |
50mg/10ml |
|
|
Paclitaxel |
IP/USP 30mg/5ml, 100mg/17ml, 260mg/43.4ml, 300mg/50ml |
|
|
Paclitaxel (Protein bound particle) |
100mg/vial |
|
|
Pegaspargase |
3750 IU/5ml |
|
|
Pemetrexed |
IP/USP 100mg/vial, 500mg/vial |
|
